The research results displayed in this graph demonstrate that for patients suffering from the cancer neuroblastoma, the presence or absence of a specific set of genes found on Chromosome 1 strongly correlates with patient outcome. Therefore, in the future this characteristic of the tumor can be used to identify those patients that would benefit from more aggressive treatment, and those best served by the current treatment protocol.